Preparing an NDA has historically meant months of manual work. Weave’s AI-native platform now handles the data extraction, authoring, content verification, and workflow automation behind that process. This frees regulatory teams to focus on strategic narrative design instead.
Parexel’s regulatory expertise across clinical, non-clinical, and CMC helped shaped how the platform meets NDA-specific demands. Weave has delivered more than 60% faster authoring timelines, without sacrificing quality.
Press release
Weave Bio Launches NDA Workflow Designed in Partnership with Parexel; Extending AI-Native Platform Coverage Across the Full Regulatory Lifecycle
Related news
Press release
Two Former FDA Leaders Join Weave Bio’s Strategic Advisory Board
Press release
Weave Bio Enables Global Submissions
News
The Regulatory Expert Is Not Obsolete: Redefining Human Expertise in an AI-Accelerated Submission Environment
Press release